BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

LOS ANGELES, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of purchasers of Beta Bionics, Inc. (“Beta Bionics” or “the Company”) (NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). Beta Bionics investors have until November 3, 2026 to seek appointment as lead plaintiff of the purported class in the Beta Bionics class action lawsuit.

GlobeNewsWire • 7 hours ago

BBNX Shareholder Alert: November 3, 2026 Lead Plaintiff Deadline in Beta Bionics, Inc. Securities Class Action - Contact Levi & Korsinsky

Wall Street stayed constructive on BBNX even after the FDA Warning Letter surfaced, with Leerink writing on January 30, 2026 that management "highlighted there have been no new issues" and Truist stating on February 17, 2026 that the letter was "not on the safety or performance of the company's insulin pump itself." A securities class action alleges those analyst views rested on Company statements that minimized more than 18,000 unreported iLet complaints Wall Street stayed constructive on BBNX even after the FDA Warning Letter surfaced, with Leerink writing on January 30, 2026 that management "highlighted there have been no new issues" and Truist stating on February 17, 2026 that the letter was "not on the safety or performance of the company's insulin pump itself." A securities class action alleges those analyst views rested on Company statements that minimized more than 18,000 unreported iLet complaints

GlobeNewsWire • 5 hours ago

BBNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 12, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) and reminds investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Newsfile Corp • 6 hours ago

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

NEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), of the important November 3, 2026 lead plaintiff deadline.

GlobeNewsWire • 9 minutes ago

Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance

SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows a series of surprise revelations about the FDA's concerns over company's automated insulin delivery system ("iLet"), each of which sent the price of Beta Bionics shares sharply lower.

PRNewsWire • 7 hours ago

Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, Oct. 12, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Beta Bionics, Inc. (BBNX) have opportunity to lead the securities fraud class action lawsuit.

PRNewsWire • 5 hours ago

INVESTOR REMINDER: Berger Montague Notifies Beta Bionics, Inc. (BBNX) Investors of a Class Action Lawsuit and Deadline

Philadelphia, Pennsylvania--(Newsfile Corp. - October 12, 2026) - Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 through February 24, 2026 (the "Class Period"). The deadline to apply for lead plaintiff is November 3, 2026.

Newsfile Corp • 9 hours ago

Kaplan Fox Notifies Beta Bionics, Inc. (BBNX) Investors of a Pending Securities Class Action Deadline on November 3, 2026

New York, New York--(Newsfile Corp. - October 12, 2026) -  Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Beta Bionics and have suffered losses, you may CLICK HERE to contact us.

Newsfile Corp • 6 hours ago

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

New York, New York--(Newsfile Corp. - October 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased Beta Bionics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp • Oct 11, 2026

BBNX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 10, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) and reminds investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Newsfile Corp • Oct 10, 2026